ASX:RVA

REVA Medical (RVA) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RVA stock logo

About REVA Medical Stock (ASX:RVA)

REVA Medical, Inc., a medical device company, focuses on the development and commercialization of polymer-based bioresorbable products for vascular applications. The company offers Fantom Encore, a bioresorbable vascular scaffold for the treatment of coronary artery disease; and MOTIV bioresorbable vascular scaffold for the treatment of below-the-knee peripheral artery disease. It sells Fantom Encore in Germany, Switzerland, Austria, the Netherlands, Belgium, Luxembourg, Italy, and Turkey. The company was formerly known as MD3, Inc. and changed its name to REVA Medical, Inc. in March 2002. REVA Medical, Inc. was founded in 1998 and is headquartered in San Diego, California.

RVA Stock News Headlines

Return of the zombie abortion bills
Watch this FREE trading tutorial while it’s still available
On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.
Watch this FREE trading tutorial while it’s still available
On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.
Sovah Health-Danville
First, the loss of a baby, then the loss of legal rights
REVA Medical Inc (RVA)
Bon Secours St. Francis Medical Center
Best Hospitals in Richmond, VA
See More Headlines
Receive RVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for REVA Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/07/2018
Today
5/04/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Ms. Regina E. Groves (Age 61)
    CEO & Director
  • Mr. Robert B. Stockman (Age 65)
    Co-Founder & Director
  • Mr. Jeffrey A. Anderson (Age 52)
    Sr. VP of Clinical & Regulatory Affairs
  • Ms. Leigh F. Elkolli (Age 47)
    CFO, Principal Accounting Officer, Corp. Sec. & Corp. Controller
  • Ms. Jessica Earley
    VP of Operations & Product Devel.

RVA Stock Analysis - Frequently Asked Questions

How were REVA Medical's earnings last quarter?

REVA Medical Inc (ASX:RVA) issued its earnings results on Tuesday, August, 7th. The company reported $0.61 earnings per share (EPS) for the quarter.

This page (ASX:RVA) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners